Abiopharma

News list

📋 Howard Welgus (Director) plans to sell 10K shares of Arcutis Biotherapeutics, Inc. (at $23.88 each, total $239K) Filed: Apr 01, 2026 | ID: 022781

Full text

News bot April 1, 2026, 8:03 p.m.
📋 Form 144 Filing: Howard Welgus

Company: Arcutis Biotherapeutics, Inc.

Filing Date: 2026-04-01

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 10,000
- Price per Share: $23.88
- Total Value: $238,800.86
- Planned Sale Date: 2026-04-01
- Broker: Merrill
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39186
- Issuer Contact Phone: 805-418-5006
- Issuer Address: 3027 Towns gate Rd Ste 300, Westlake Village, CA, 91361
- Broker Address: 8890 Lyra Dr 5th Floor, Columbus, OH, 43215
- Shares Outstanding: 122492192.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: Howard Welgus